Stock 1099 SINOPHARM GROUP CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sinopharm Group Co. Ltd.

Equities

1099

CNE100000FN7

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:03 2024-05-23 am EDT 		5-day change 1st Jan Change
21.45 HKD -0.23% Intraday chart for Sinopharm Group Co. Ltd. -4.88% +4.89%
May. 15 China Grants Registration Approval for Shanghai Shyndec Pharmaceutical Unit's Flu Injection MT
May. 14 China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status MT

Sales per Business

HKD in Million2022Weight2023Weight Delta
Pharmaceutical Distribution
71.0 %
455,592 71.0 % 468,250 71.0 % +2.78%
Medical Devices Distribution
21.7 %
139,088 21.7 % 143,190 21.7 % +2.95%
Retail Pharmacy
5.9 %
37,681 5.9 % 38,660 5.9 % +2.60%
Other
1.4 %
9,720 1.5 % 9,108 1.4 % -6.30%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
642,080 100.0 % 659,208 100.0 % +2.67%

Managers

Managers TitleAgeSince
Yong Liu PSD
 President 55 09-01-08
Shuang Jun Xu PRN
 Corporate Officer/Principal 55 11-02-28
Zhong Xi Cai PRN
 Corporate Officer/Principal 59 10-04-30
Guang Fu Li PRN
 Corporate Officer/Principal 66 10-04-30
Jun Lu PRN
 Corporate Officer/Principal 66 04-06-28
Yi Jian Wu SEC
 Corporate Secretary 54 -
Xiu Chang Jiang PRN
 Corporate Officer/Principal 60 10-04-30

Members of the board

Members of the board TitleAgeSince
Qi Yu Chen BRD
 Director/Board Member 52 10-04-30
Xiao Hui Guan BRD
 Director/Board Member 53 19-01-10
Yi Jian Wu SEC
 Corporate Secretary 54 -
Pei Yu Li BRD
 Director/Board Member 61 20-09-17
Jin Dong Deng BRD
 Director/Board Member 60 07-08-29
De Yong Wen BRD
 Director/Board Member 52 17-08-31
Kan Wang BRD
 Director/Board Member 39 22-12-22
Rong Li Feng BRD
 Director/Board Member 49 20-06-10
Sheng Hao Shi BRD
 Director/Board Member 55 23-06-14
Peng Wang BRD
 Director/Board Member 42 22-12-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,778,845,451 0 0 42.99 %
Stock B 1 1,341,810,740 1,341,651,731 ( 99.99 %) 0

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
7.602 %
102,000,993 7.602 % 259 M $
Lazard Asset Management LLC
7.005 %
93,990,820 7.005 % 238 M $
JPMorgan Asset Management (Asia Pacific) Ltd.
3.223 %
43,246,400 3.223 % 110 M $
BlackRock Fund Advisors
2.447 %
32,836,000 2.447 % 83 M $
Value Partners Ltd.
1.760 %
23,609,200 1.760 % 60 M $
FIAM LLC
1.707 %
22,907,295 1.707 % 58 M $
BlackRock Advisors (UK) Ltd.
1.585 %
21,263,397 1.585 % 54 M $
Bosera Asset Management Co., Ltd.
0.7800 %
10,466,000 0.7800 % 27 M $
Lazard Asset Management Ltd.
0.4511 %
6,052,955 0.4511 % 15 M $
China Asset Management Co., Ltd.
0.4443 %
5,961,600 0.4443 % 15 M $
NameEquities%Valuation
RhumbLine Advisers LP
0.000238 %
638 0.000238 % 8 863 $
GAMMA Investing LLC
0.000117 %
313 0.000117 % 4 348 $
PNC Investments LLC
0.000088 %
236 0.000088 % 3 279 $
NameEquities%Valuation
Sinopharm Industrial Investment Co., Ltd.
88.35 %
1,571,555,953 88.35 % 3 987 M $
China State-Owned Assets Supervision & Admn Commission
11.65 %
207,289,498 11.65 % 526 M $

Holdings

NameEquities%Valuation
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.
63.77%
 304,842,487 63.77% 1,478,851,873 $
CHINA NATIONAL MEDICINES CORPORATION LTD.
100.00%
 201,156,574 100.00% 965,296,086 $
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
1.42%
 19,068,440 1.42% 28,649,378 $

Company contact information

Sinopharm Group Co., Ltd.

Sinopharm Group Building No. 385, East Longhua Road

200023, Shanghai

+86 21 2305 2666

http://ir.sinopharmgroup.com.cn
address Sinopharm Group Co. Ltd.(1099)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Ratings for Sinopharm Group Co. Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
19.89 CNY
Average target price
24.61 CNY
Spread / Average Target
+23.72%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+4.89% 8.59B
MCKESSON CORPORATION Stock McKesson Corporation
+20.53% 72.45B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-4.71% 23.46B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.11% 8.35B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-23.73% 7.88B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+13.92% 5.21B
EBOS GROUP LIMITED Stock EBOS Group Limited
-0.59% 4.11B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+7.85% 4.09B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+20.65% 3.6B
MEDIPAL HOLDINGS CORPORATION Stock MediPal Holdings Corporation
-1.82% 2.98B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 1099 Stock
  4. Company Sinopharm Group Co. Ltd.